AUSTIN, TX – Tekton Research, a leading clinical research company specializing in clinical trials for pharmaceuticals and device companies, is thrilled to announce the appointment of Corey Collins as their new Chief Financial Officer (CFO). With over 20 years of invaluable financial leadership experience, Corey brings a wealth of expertise to the forefront of Tekton’s executive team.
“Corey joining the Tektonn marks an exciting new chapter for Tekton Research,” said Kip McKenzie, CEO at Tekton Research. “His extensive background in financial management and strategic leadership will undoubtedly drive our company’s growth trajectory to new heights.”
Corey holds a Bachelor’s degree in accounting from the University of South Carolina and is a Certified Public Accountant. His dedication and proficiency in financial management have already set him on a path to enhance Tekton’s financial landscape.
Prior to joining Tekton Research, Corey made significant contributions to the financial success of organizations within the manufacturing and pharmaceutical sectors. His tenure at reputable companies such as American Expediting, Dicalite Management Group, and PCI Pharma Services attests to his adeptness in steering financial strategies towards achievement and sustainability. Notably, Corey’s early career comprised pivotal financial leadership roles at GE Water & Process Technologies and Deloitte, further solidifying his expertise and versatility in the financial domain.
“I am excited to join Tekton Research, a successful and unique leader in the site network space,” said Collins. “I believe that Tekton Research is very well-positioned and has a tremendous growth potential based on the impressive reputation and depth of expertise.”
For more information or to request a meeting, contact [email protected].
